- Scrip Originals
Myst Therapeutics, Inc.
Already a Biomedtracker subscriber? You have access to the full company record through your subscription
Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Myst Therapeutics, Inc.
Genentech will use the X-Chem platform to obtain leads against multiple oncology targets. Lilly partners with Merus on CD3-targeting T-cell therapy candidates.
- Gene Therapy, Cell Therapy